Selected research
Market Outlook & Growth Opportunities
Global Farm Animal Vaccine Market Outlook and Growth Opportunities 2026
Market perspective
The global Farm Animal Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Farm Animal Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Farm Animal Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Farm Animal Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Farm Animal Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Farm Animal Vaccine market include Avimex Animal, Bio-Labs, Boehringer Ingelheim, CAHIC, CAVAC, Ceva, ChengDu Tecbond, DHN and Elanco/Eli Lilly, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Farm Animal Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Farm Animal Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Farm Animal Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Farm Animal Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.
Farm Animal Vaccine Segment by Company
Avimex Animal
Bio-Labs
Boehringer Ingelheim
CAHIC
CAVAC
Ceva
ChengDu Tecbond
DHN
Elanco/Eli Lilly
FATRO
HVRI
Jinyu Bio-Technology
Kyoto Biken
Ringpu Biology
Vaksindo
Virbac
WINSUN
Yebio
Zoetis
Merck
Farm Animal Vaccine Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other
Farm Animal Vaccine Segment by Application
Swine
Cow
Chicken
Other
Farm Animal Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Farm Animal Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Farm Animal Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Farm Animal Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Farm Animal Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Farm Animal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Farm Animal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Farm Animal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Farm Animal Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Farm Animal Vaccine industry.
Chapter 3: Detailed analysis of Farm Animal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Farm Animal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Farm Animal Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Live Attenuated Vaccines
- Inactivated Vaccines
- Other
Applications
- Swine
- Cow
- Chicken
- Other
Companies covered
- Avimex Animal
- Bio-Labs
- Boehringer Ingelheim
- CAHIC
- CAVAC
- Ceva
- ChengDu Tecbond
- DHN
- Elanco/Eli Lilly
- FATRO
- HVRI
- Jinyu Bio-Technology
- Kyoto Biken
- Ringpu Biology
- Vaksindo
- Virbac
- WINSUN
- Yebio
- Zoetis
- Merck
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Farm Animal Vaccine Sales Value (2021-2032)
- 1.2.2 Global Farm Animal Vaccine Sales Volume (2021-2032)
- 1.2.3 Global Farm Animal Vaccine Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Farm Animal Vaccine Market Dynamics
- 2.1 Farm Animal Vaccine Industry Trends
- 2.2 Farm Animal Vaccine Industry Drivers
- 2.3 Farm Animal Vaccine Industry Opportunities and Challenges
- 2.4 Farm Animal Vaccine Industry Restraints
3 Farm Animal Vaccine Market by Company
- 3.1 Global Farm Animal Vaccine Company Revenue Ranking in 2025
- 3.2 Global Farm Animal Vaccine Revenue by Company (2021-2026)
- 3.3 Global Farm Animal Vaccine Sales Volume by Company (2021-2026)
- 3.4 Global Farm Animal Vaccine Average Price by Company (2021-2026)
- 3.5 Global Farm Animal Vaccine Company Ranking (2024-2026)
- 3.6 Global Farm Animal Vaccine Company Manufacturing Base and Headquarters
- 3.7 Global Farm Animal Vaccine Company Product Type and Application
- 3.8 Global Farm Animal Vaccine Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Farm Animal Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Farm Animal Vaccine Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Farm Animal Vaccine Market by Type
- 4.1 Farm Animal Vaccine Type Introduction
- 4.1.1 Live Attenuated Vaccines
- 4.1.2 Inactivated Vaccines
- 4.1.3 Other
- 4.2 Global Farm Animal Vaccine Sales Volume by Type
- 4.2.1 Global Farm Animal Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Farm Animal Vaccine Sales Volume by Type (2021-2032)
- 4.2.3 Global Farm Animal Vaccine Sales Volume Share by Type (2021-2032)
- 4.3 Global Farm Animal Vaccine Sales Value by Type
- 4.3.1 Global Farm Animal Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Farm Animal Vaccine Sales Value by Type (2021-2032)
- 4.3.3 Global Farm Animal Vaccine Sales Value Share by Type (2021-2032)
5 Farm Animal Vaccine Market by Application
- 5.1 Farm Animal Vaccine Application Introduction
- 5.1.1 Swine
- 5.1.2 Cow
- 5.1.3 Chicken
- 5.1.4 Other
- 5.2 Global Farm Animal Vaccine Sales Volume by Application
- 5.2.1 Global Farm Animal Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Farm Animal Vaccine Sales Volume by Application (2021-2032)
- 5.2.3 Global Farm Animal Vaccine Sales Volume Share by Application (2021-2032)
- 5.3 Global Farm Animal Vaccine Sales Value by Application
- 5.3.1 Global Farm Animal Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Farm Animal Vaccine Sales Value by Application (2021-2032)
- 5.3.3 Global Farm Animal Vaccine Sales Value Share by Application (2021-2032)
6 Farm Animal Vaccine Regional Sales and Value Analysis
- 6.1 Global Farm Animal Vaccine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Farm Animal Vaccine Sales by Region (2021-2032)
- 6.2.1 Global Farm Animal Vaccine Sales by Region: 2021-2026
- 6.2.2 Global Farm Animal Vaccine Sales by Region (2027-2032)
- 6.3 Global Farm Animal Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Farm Animal Vaccine Sales Value by Region (2021-2032)
- 6.4.1 Global Farm Animal Vaccine Sales Value by Region: 2021-2026
- 6.4.2 Global Farm Animal Vaccine Sales Value by Region (2027-2032)
- 6.5 Global Farm Animal Vaccine Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Farm Animal Vaccine Sales Value (2021-2032)
- 6.6.2 North America Farm Animal Vaccine Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Farm Animal Vaccine Sales Value (2021-2032)
- 6.7.2 Europe Farm Animal Vaccine Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Farm Animal Vaccine Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Farm Animal Vaccine Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Farm Animal Vaccine Sales Value (2021-2032)
- 6.9.2 South America Farm Animal Vaccine Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Farm Animal Vaccine Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Farm Animal Vaccine Sales Value Share by Country, 2025 VS 2032
7 Farm Animal Vaccine Country-level Sales and Value Analysis
- 7.1 Global Farm Animal Vaccine Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Farm Animal Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Farm Animal Vaccine Sales by Country (2021-2032)
- 7.3.1 Global Farm Animal Vaccine Sales by Country (2021-2026)
- 7.3.2 Global Farm Animal Vaccine Sales by Country (2027-2032)
- 7.4 Global Farm Animal Vaccine Sales Value by Country (2021-2032)
- 7.4.1 Global Farm Animal Vaccine Sales Value by Country (2021-2026)
- 7.4.2 Global Farm Animal Vaccine Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.9.2 France Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.16.2 China Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.19.2 India Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Farm Animal Vaccine Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Farm Animal Vaccine Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Farm Animal Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Avimex Animal
- 8.1.1 Avimex Animal Company Information
- 8.1.2 Avimex Animal Business Overview
- 8.1.3 Avimex Animal Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Avimex Animal Farm Animal Vaccine Product Portfolio
- 8.1.5 Avimex Animal Recent Developments
- 8.2 Bio-Labs
- 8.2.1 Bio-Labs Company Information
- 8.2.2 Bio-Labs Business Overview
- 8.2.3 Bio-Labs Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Bio-Labs Farm Animal Vaccine Product Portfolio
- 8.2.5 Bio-Labs Recent Developments
- 8.3 Boehringer Ingelheim
- 8.3.1 Boehringer Ingelheim Company Information
- 8.3.2 Boehringer Ingelheim Business Overview
- 8.3.3 Boehringer Ingelheim Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Boehringer Ingelheim Farm Animal Vaccine Product Portfolio
- 8.3.5 Boehringer Ingelheim Recent Developments
- 8.4 CAHIC
- 8.4.1 CAHIC Company Information
- 8.4.2 CAHIC Business Overview
- 8.4.3 CAHIC Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.4.4 CAHIC Farm Animal Vaccine Product Portfolio
- 8.4.5 CAHIC Recent Developments
- 8.5 CAVAC
- 8.5.1 CAVAC Company Information
- 8.5.2 CAVAC Business Overview
- 8.5.3 CAVAC Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.5.4 CAVAC Farm Animal Vaccine Product Portfolio
- 8.5.5 CAVAC Recent Developments
- 8.6 Ceva
- 8.6.1 Ceva Company Information
- 8.6.2 Ceva Business Overview
- 8.6.3 Ceva Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Ceva Farm Animal Vaccine Product Portfolio
- 8.6.5 Ceva Recent Developments
- 8.7 ChengDu Tecbond
- 8.7.1 ChengDu Tecbond Company Information
- 8.7.2 ChengDu Tecbond Business Overview
- 8.7.3 ChengDu Tecbond Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.7.4 ChengDu Tecbond Farm Animal Vaccine Product Portfolio
- 8.7.5 ChengDu Tecbond Recent Developments
- 8.8 DHN
- 8.8.1 DHN Company Information
- 8.8.2 DHN Business Overview
- 8.8.3 DHN Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.8.4 DHN Farm Animal Vaccine Product Portfolio
- 8.8.5 DHN Recent Developments
- 8.9 Elanco/Eli Lilly
- 8.9.1 Elanco/Eli Lilly Company Information
- 8.9.2 Elanco/Eli Lilly Business Overview
- 8.9.3 Elanco/Eli Lilly Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Elanco/Eli Lilly Farm Animal Vaccine Product Portfolio
- 8.9.5 Elanco/Eli Lilly Recent Developments
- 8.10 FATRO
- 8.10.1 FATRO Company Information
- 8.10.2 FATRO Business Overview
- 8.10.3 FATRO Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.10.4 FATRO Farm Animal Vaccine Product Portfolio
- 8.10.5 FATRO Recent Developments
- 8.11 HVRI
- 8.11.1 HVRI Company Information
- 8.11.2 HVRI Business Overview
- 8.11.3 HVRI Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.11.4 HVRI Farm Animal Vaccine Product Portfolio
- 8.11.5 HVRI Recent Developments
- 8.12 Jinyu Bio-Technology
- 8.12.1 Jinyu Bio-Technology Company Information
- 8.12.2 Jinyu Bio-Technology Business Overview
- 8.12.3 Jinyu Bio-Technology Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Jinyu Bio-Technology Farm Animal Vaccine Product Portfolio
- 8.12.5 Jinyu Bio-Technology Recent Developments
- 8.13 Kyoto Biken
- 8.13.1 Kyoto Biken Company Information
- 8.13.2 Kyoto Biken Business Overview
- 8.13.3 Kyoto Biken Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Kyoto Biken Farm Animal Vaccine Product Portfolio
- 8.13.5 Kyoto Biken Recent Developments
- 8.14 Ringpu Biology
- 8.14.1 Ringpu Biology Company Information
- 8.14.2 Ringpu Biology Business Overview
- 8.14.3 Ringpu Biology Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Ringpu Biology Farm Animal Vaccine Product Portfolio
- 8.14.5 Ringpu Biology Recent Developments
- 8.15 Vaksindo
- 8.15.1 Vaksindo Company Information
- 8.15.2 Vaksindo Business Overview
- 8.15.3 Vaksindo Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Vaksindo Farm Animal Vaccine Product Portfolio
- 8.15.5 Vaksindo Recent Developments
- 8.16 Virbac
- 8.16.1 Virbac Company Information
- 8.16.2 Virbac Business Overview
- 8.16.3 Virbac Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Virbac Farm Animal Vaccine Product Portfolio
- 8.16.5 Virbac Recent Developments
- 8.17 WINSUN
- 8.17.1 WINSUN Company Information
- 8.17.2 WINSUN Business Overview
- 8.17.3 WINSUN Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.17.4 WINSUN Farm Animal Vaccine Product Portfolio
- 8.17.5 WINSUN Recent Developments
- 8.18 Yebio
- 8.18.1 Yebio Company Information
- 8.18.2 Yebio Business Overview
- 8.18.3 Yebio Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Yebio Farm Animal Vaccine Product Portfolio
- 8.18.5 Yebio Recent Developments
- 8.19 Zoetis
- 8.19.1 Zoetis Company Information
- 8.19.2 Zoetis Business Overview
- 8.19.3 Zoetis Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Zoetis Farm Animal Vaccine Product Portfolio
- 8.19.5 Zoetis Recent Developments
- 8.20 Merck
- 8.20.1 Merck Company Information
- 8.20.2 Merck Business Overview
- 8.20.3 Merck Farm Animal Vaccine Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Merck Farm Animal Vaccine Product Portfolio
- 8.20.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Farm Animal Vaccine Value Chain Analysis
- 9.1.1 Farm Animal Vaccine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Farm Animal Vaccine Sales Mode & Process
- 9.2 Farm Animal Vaccine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Farm Animal Vaccine Distributors
- 9.2.3 Farm Animal Vaccine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst